An Open Phase I Single Dose Escalation Study of Bivatuzumab Mertansine Administered Intravenously in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck With Repeated Administration in Patients With Clinical Benefit
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003750/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
maximum tolerated dose (MTD), safety, pharmacokinetics, efficacy of bivatuzumab mertansine
提供机构：
Vivli
创建时间：
2019-04-12
